Literature DB >> 32021860

Hidradenitis Suppurativa or Hidradenitis Suppurativa-Like Lesions Located on Amputation Stumps? Description of 2 Cases.

Nicolas Kluger1, Philippe Guillem2,3, Minttu Kivivuori4, Kirsi Isoherranen1.   

Abstract

Hidradenitis suppurativa (HS) is a chronic and recurrent inflammatory skin disorder affecting mainly the areas rich in apocrine sweat glands, such as the axillae, groins and buttocks. The role of mechanical pressure and friction due to clothing in the pathogenesis of HS lesions has been previously stressed. Here, we report 2 middle-aged men who presented with HS lesions/HS-like lesions on their amputation stump and review 2 additional cases from the literature. Management was challenging as 2 patients needed tumor necrosis αinhibitor while deroofing/surgery was the option for the 2 others. These cases highlight that mechanical pressure and friction are environmental factors that can play a role in the pathogenesis of HS lesions.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Amputation; Friction; Hidradenitis suppurativa; Prosthesis; Stump

Year:  2019        PMID: 32021860      PMCID: PMC6995964          DOI: 10.1159/000503153

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  19 in total

1.  Epidermoid cysts in amputees.

Authors:  M F ALLENDE; S W LEVY; G H BARNES
Journal:  Acta Derm Venereol       Date:  1963       Impact factor: 4.437

Review 2.  Skin problems in lower limb amputees: an overview by case reports.

Authors:  H E J Meulenbelt; J H B Geertzen; P U Dijkstra; M F Jonkman
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-02       Impact factor: 6.166

3.  Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.

Authors:  Robert L Henderson
Journal:  J Drugs Dermatol       Date:  2006 Nov-Dec       Impact factor: 2.114

Review 4.  Ancient adaptations of human skin: why do we retain sebaceous and apocrine glands?

Authors:  Omar Lupi
Journal:  Int J Dermatol       Date:  2008-07       Impact factor: 2.736

5.  Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.

Authors:  J Delaunay; A P Villani; P Guillem; A Tristan; A Boibieux; D Jullien
Journal:  Br J Dermatol       Date:  2017-12-07       Impact factor: 9.302

6.  Should Hidradenitis Suppurativa Be Included in Dermatoses Showing Koebnerization? Is It Friction or Fiction?

Authors:  Jurr Boer
Journal:  Dermatology       Date:  2017-05-16       Impact factor: 5.366

7.  Skin disorders in amputees.

Authors:  C C Lyon; J Kulkarni; E Zimerson; E Van Ross; M H Beck
Journal:  J Am Acad Dermatol       Date:  2000-03       Impact factor: 11.527

8.  European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.

Authors:  C C Zouboulis; N Desai; L Emtestam; R E Hunger; D Ioannides; I Juhász; J Lapins; L Matusiak; E P Prens; J Revuz; S Schneider-Burrus; J C Szepietowski; H H van der Zee; G B E Jemec
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-01-30       Impact factor: 6.166

9.  A clinical evaluation of skin disorders of lower limb amputation sites.

Authors:  Emine Colgecen; Murat Korkmaz; Kemal Ozyurt; Ugur Mermerkaya; Cigdem Kader
Journal:  Int J Dermatol       Date:  2015-09-29       Impact factor: 2.736

Review 10.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.